The use of FDG-PET to guide consolidative radiotherapy in patients with advanced-stage Hodgkin lymphoma with residual abnormalities on CT scan following ABVD chemotherapy

被引：0
|
作者：
Savage, K. J.
Connors, J. M.
Klasa, R. J.
Hoskins, P.
Shenkier, T. N.
Gascoyne, R. D.
Bhimji, S.
Pickles, T.
Benard, F.
Wilson, D.
Sehn, L. H.
机构：
[1] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
[2] British Columbia Canc Agcy, Ctr Lymphoid Canc, Vancouver, BC V5Z 4E6, Canada
[3] British Columbia Canc Agcy, Dept Radiol, Vancouver, BC V5Z 4E6, Canada
[4] British Columbia Canc Agcy, Dept Nucl Med, Vancouver, BC V5Z 4E6, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8034
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Clinical impact of FDG-PET/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma
    Hutchings, Martin
    Loft, Annika
    Hansen, Mads
    Berthelsen, Anne Kiil
    Specht, Lena
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2007, 78 (03) : 206 - 212
  • [22] The prognostic value of the tumor/microenvironment signature compared to early pet scan in advanced-stage, ABVD-treated Hodgkin lymphoma patients
    Gallamini, A.
    Agostinelli, C.
    Rigacci, L.
    D'Amore, F.
    Merli, F.
    Zinzani, P.
    Vitolo, U.
    Patti, C.
    Stelitano, C.
    Di Raimondo, F.
    Levis, A.
    Trentin, L.
    Chisesi, T.
    Kamper, P.
    Pileri, S.
    ANNALS OF ONCOLOGY, 2008, 19 : 125 - 125
  • [23] Role of Radiotherapy after Assessment of Residual Bulky Tumor using FDG-PET in Patients with Advanced-stage Hodgkin Lymphoma: Final Report of the GHSG HD15 Trial
    Eich, H. T.
    Kobe, C.
    Dietlein, M.
    Kriz, J.
    Haverkamp, H.
    Fuchs, M.
    Borchmann, P.
    Engert, A.
    Mueller, R. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S2 - S3
  • [24] Assessment of Residual Bulky Tumor Using FDG-PET In Patients with Advanced-Stage Hodgkin Lymphoma After Completion of Chemotherapy: Final Report of the GHSG HD15 Trial
    Engert, Andreas
    Kobe, Carsten
    Markova, Jana
    Haverkamp, Heinz
    Borchmann, Peter
    Hitz, Felicitas
    Zijlstra, Josee
    Eich, Hans
    Mueller, Rolf-Peter
    Dietlein, Markus
    Diehl, Volker
    BLOOD, 2010, 116 (21) : 336 - 336
  • [25] Assessment of residual bulky tumor using FDG-PET in patients with advanced-stage Hodgkin Lymphoma after completion of chemotherapy: Final report of the GHSG HD15 trial
    Eich, H. T.
    Kobe, C.
    Kriz, J.
    Baues, C.
    Haverkamp, H.
    Fuchs, M.
    Dietlein, M.
    Engert, A.
    Mueller, R. -P.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 : 48 - 48
  • [26] Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses
    Gallamini, Andrea
    Patti, Caterina
    Viviani, Simonetta
    Rossi, Andrea
    Fiore, Francesca
    Di Raimondo, Francesco
    Cantonetti, Maria
    Stelitano, Caterina
    Feldman, Tatyana
    Gavarotti, Paolo
    Sorasio, Roberto
    Mule, Antonino
    Leone, Monica
    Rambaldi, Alessandro
    Biggi, Alberto
    Barrington, Sally
    Fallanca, Federico
    Ficola, Umberto
    Chauvie, Stephane
    Gianni, Alessandro Massimo
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 152 (05) : 551 - 560
  • [27] The value of dual point interim FDG-PET/CT assessment in a patient with advanced Hodgkin's lymphoma (HL) with bulky masses treated with ABVD chemotherapy
    Zaucha, J.
    Malkowski, B.
    Gallamini, A.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 82 : S27 - S28
  • [28] CT and FDG-PET for the evaluation of residual and recurrent lymphoma in patients (pts) with Hodgkin's disease (HD).
    Sökler, M
    Dittmann, H
    Dohmen, B
    Baumann, C
    Kopp, A
    Kollmannsberger, C
    Bares, R
    Kanz, L
    Bokemeyer, C
    ANNALS OF ONCOLOGY, 2000, 11 : 100 - 100
  • [29] EARLY CHEMOTHERAPY INTENSIFICATION WITH BEACOPP IN HIGH-RISK, INTERIM-PET POSITIVE, ADVANCED-STAGE, ABVD-TREATED HODGKIN LYMPHOMA PATIENTS
    Fiore, F.
    Patti, K.
    Viviani, S.
    Rossi, A.
    Di Raimondo, F.
    Cantonetti, M.
    Stelitano, C.
    Feldman, T.
    Gavarotti, P.
    Sorasio, R.
    Biggi, A.
    Barrington, S.
    Gallamini, A.
    HAEMATOLOGICA, 2010, 95 : S22 - S22
  • [30] FDG-PET for assessment of early therapy response after 4 cycles of chemotherapy in advanced stage Hodgkin lymphoma
    Markova, J.
    Skopalova, M.
    Kobe, C.
    Klaskova, K.
    Zikavska, L.
    Polivka, J.
    Vernerova, Z.
    Kamaradova, K.
    Dedeckova, K.
    Kozak, T.
    ANNALS OF ONCOLOGY, 2008, 19 : 135 - 135
12345